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background: Increasing numbers of novel parameters for central blood pressure(BP) have been developed to predict cardiovascular 
mortality. But it remains largely unknown whether these indices are fully validated against invasive study or their predictive values are 
consistent among different devices.
Methods: For validation, we enrolled 192 patients who underwent elective coronary angiography. Brachial and central BPs were measured 
noninvasively with Mobil-O-Graph®, invasively with a fluid-filled catheter. Significant coronary artery disease (sCAD) was defined to have 
at least one stenosis over 50% or history of coronary angioplasty. In 85 patients with thorough data acquisition, we specifically validated 
amplification of blood pressure and evaluated their contribution for sCAD.
Results: In 192 patients, noninvasively measured central systolic, diastolic, and pulse pressures all showed good linear correlation with 
invasive data ( central systolic BP: r=0.76, central diastolic BP: r=0.66, central pulse pressure(PP): r=0.62; all p<0.001). Bland-Altman Plot 
analysis indicated errors were permissive, although deviation was consistently large (central systolic BP: -5.1±19.3mmHg, central diastolic 
BP:-16.0±10.0mmHg, central PP: 10.1±18.0mHg). On validation for PP amplification (PPA) and systolic BP amplification (SBPA) in selected 
85 patients, neither noninvasive PPA nor SBPA showed any correlation with invasive values (PPA: r=0.00, p=1.00; SBPA:r=0.03, p=0.79). 
There were also substantial discrepancies between methods (PPA: -11.0±20.3, SBPA:24.3±13.6 ). We further evaluated the relative risk of 
amplification indices for sCAD by multivariate logistic regression analysis. After adjusting for traditional risk factors, both invasive PPA and 
SBPA remained significant (odds ratio [confidence interval] : PPA1.17 [1.01-1.35], SBPA1.13 [1.01-1.26]). On the other hand, noninvasive 
PPA and SBPA showed no contribution.
conclusion:  While noninvasive central blood pressure values showed good correlation with invasive ones, noninvasive amplification 
indices are rather unrelated to invasive data, and as such useless in predicting sCAD.
